EUVIMEDFaigh amach EUVIMED
Open access

miR-141-3p promotes paclitaxel resistance by attenuating ferroptosis via the Keap1-Nrf2 signaling pathway in breast cancer

Wan-Li Duan, Xue-Jie Wang, Ai Guo, Li-Hui Gu, Zhi-Mei Sheng, Hao Luo, Li-Xia Yang, Wen-Hao Wang, Bao-Gang Zhang

Journal of Cancer · 2024 · 15 (17) · 5622-5635

DOI: 10.7150/jca.96608 ↗

At a glance

Journal article in Journal of Cancer, 2024. Written by Wan-Li Duan and 8 co-authors. Institution: Medical Research Center, Shaoxing People's Hospital, No.568, Zhongxing North Road, Shaoxing 312000, Zhejiang Province, China. Cited 20 times so far (Crossref). The full text is freely available in PubMed Central.

AchoimreSubjectsSonraí leabharliostaCiteRelated studies

Abstract (original language)

Purpose

Breast cancer poses a huge threat to the lives and health of women worldwide. However, drug resistance makes the treatment of breast cancer challenging. This study aims to investigate the effect of miR-141-3p on paclitaxel resistance and its underlying mechanisms in breast cancer.

Methods

Using bioinformatics analysis and qRT-PCR to explore the potential molecule miR-141-3p. Specific binding of miR-141-3p to Keap1 was determined by using a dual luciferase reporter assay. qRT-PCR and Western blot were utilized to observe the expression of miR-141-3p, Keap1, Nrf2, SLC7A11 and GPX4. GSH/GSSG content, MDA content and JC-1 assays were used to observe the ferroptosis levels of breast cancer cells. CCK-8 assay was used to observe the cell viability of breast cancer cells. Tumor subcutaneous transplantation experiment was used to understand the effect of miR-141-3p on paclitaxel resistance in breast cancer in vivo.

Results

In the present study, miR-141-3p was found to be highly expressed and associated with poor prognosis in breast cancer. miR-141-3p inhibited Keap1 expression, promoted Nrf2 expression, and facilitated paclitaxel resistance in breast cancer cells. Inhibition of miR-141-3p promoted Keap1 expression, inhibited Nrf2 and its downstream SLC7A11-GSH-GPX4 signaling pathway, as well as promoted ferroptosis in cancer cells, and inhibited paclitaxel and RSL3 resistance. ML385 blocks the effect of miR-141-3p on paclitaxel resistance and ferroptosis resistance in breast cancer cells. In vivo, miR-141-3p mimics promoted paclitaxel resistance, whereas miR-141-3p inhibitors inhibited paclitaxel resistance in breast cancer cells.

Conclusion

This work revealed that modulation of the Keap1-Nrf2 signaling pathway by miR-141-3p promoted paclitaxel resistance via regulating ferroptosis in breast cancer cells.

Subjects

Author keywords

Keap1-Nrf2 signaling pathwaybreast cancerferroptosismiR-141-3ppaclitaxel resistance

Authors and institutions

  • Medical Research Center, Shaoxing People's Hospital, No.568, Zhongxing North Road, Shaoxing 312000, Zhejiang Province, China.
  • Department of Diagnostic Pathology, School of Basic Medical Sciences, Shandong Second Medical University, Weifang 261041, China.
  • Department of Pathology, Shaoxing People's Hospital, No.568, Zhongxing North Road, Shaoxing 312000, Zhejiang Province, China.
  • Department of Pathology, Affiliated Hospital of Shandong Second Medical University, Weifang 261041, Shandong, China.
  • Department of Medical Oncology, Affiliated Hospital of Shandong Second Medical University, Weifang 261041, China.

Cite

APA

Duan, W. L., Wang, X. J., Guo, A., Gu, L. H., Sheng, Z. M., Luo, H., Yang, L. X., Wang, W. H., & Zhang, B. G. (2024). miR-141-3p promotes paclitaxel resistance by attenuating ferroptosis via the Keap1-Nrf2 signaling pathway in breast cancer. Journal of Cancer, 15(17), 5622-5635. https://doi.org/10.7150/jca.96608

Vancouver

Duan WL, Wang XJ, Guo A, Gu LH, Sheng ZM, Luo H, et al. miR-141-3p promotes paclitaxel resistance by attenuating ferroptosis via the Keap1-Nrf2 signaling pathway in breast cancer. Journal of Cancer. 2024;15(17):5622-5635. doi:10.7150/jca.96608

BibTeX
@article{Duan2024,
  author = {Duan, Wan-Li and Wang, Xue-Jie and Guo, Ai and Gu, Li-Hui and Sheng, Zhi-Mei and Luo, Hao and Yang, Li-Xia and Wang, Wen-Hao and Zhang, Bao-Gang},
  title = {miR-141-3p promotes paclitaxel resistance by attenuating ferroptosis via the Keap1-Nrf2 signaling pathway in breast cancer},
  journal = {Journal of Cancer},
  year = {2024},
  volume = {15},
  number = {17},
  pages = {5622--5635},
  doi = {10.7150/jca.96608}
}
Start for free →